Progesterone in Threatened Abortion

Summary

The main objective of this study will be to assess the efficacy of natural progesterone at a daily dose of 25 mg/bid in the maintenance of early pregnancy in women with symptoms of threatened abortion. The secondary objectives will be the efficacy of progesterone in reducing both pain and uterine contractions.

Timeline

Start

2017-04-04

Primary completion

2018-05-02

Completion

2018-05-02

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty in recruitment”

Drugs

Indications